Idled since midsummer 2000, MDS Nordion's Maple 1 reactor may soon be back online. The company, which supplies most of the world's medical isotopes, has been authorized by the Canadian Nuclear Safety Commission to restart the reactor in low-power mode.
Idled since midsummer 2000, MDS Nordion's Maple 1 reactor may soon be back online. The company, which supplies most of the world's medical isotopes, has been authorized by the Canadian Nuclear Safety Commission to restart the reactor in low-power mode. Located in Chalk River near Ottawa, the reactor was taken offline in July 2000 after problems occurred during testing of its shutoff rods. When fully operational, either of the two 10-Mw Maple reactors will be able to exceed the world's current demand for molybdenum-99, iodine-131, and xenon-133.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
AI Adjudication Bolsters Chest CT Assessment of Lung Adenocarcinoma
April 11th 2024The inclusion of simulated adjudication for resolving discordant nodule classifications in a deep learning model for assessing lung adenocarcinoma on chest CT resulted in a 12 percent increase in sensitivity rate.